General Goal: To know the major cause(s) of these infections, how they are transmitted, and the major manifestations of the infections.
Specific Educational Objectives: The student should be able to:
1. Identify the common cause of vaginitis discussed in this handout. Know the common or pathognomonic signs of the diseases.
2. Describe the major manifestations of each infection and differentiate it from other infections in the course.
3. Describe how you diagnose, treat and prevent these infections.
Reading: MEDICAL MICROBIOLOGY by P.R. Murray, K.S. Rosenthal, G.S. Kobayashi and M.A. Pfaller, 3rd Edition. depends on the organism.
F.S. Southwick, Infectious Diseases in 30 Days, 1st edition, McGraw Hill. p. 289-318.
Lecture: Dr. Neal R. Chamberlain
References:
Diseases characterized by vaginal discharge.
A recent Gallup survey found that very few women have a thorough understanding of vaginitis. While 95 percent of women surveyed had heard about yeast infections only 36 percent had ever heard of a more common vaginal infection called bacterial vaginosis (BV).
Bacterial Vaginosis (BV) due to Gardnerella vaginalis, Mycoplasma hominis and various anaerobic bacteria including Mobiluncus sp., and Prevotella sp.
BV is the most common vaginal infection. The disease has been found in 12 to 25 percent of women in routine clinic populations, 10 to 26 percent of women in obstetrics clinics and 32 to 64 percent of women in clinics for sexually transmitted diseases (STDs).
Other organisms can cause vaginitis. Candida albicans (Candidiasis)
and Trichomonas vaginalis (Trichomoniasis). These infections
of the vagina are discussed in this handout as well.
Vaginal infections are often accompanied by vaginitis, which is an inflammation
of the vagina characterized by discharge, irritation, and/or itching. The
cause of vaginitis cannot be adequately determined solely on the basis
of symptoms or a physical examination. Laboratory tests allowing microscopic
evaluation of vaginal fluid are required for a correct diagnosis. A variety
of effective drugs are available for treating vaginal infections and accompanying
vaginitis.
A. Etiology
Bacterial Vaginosis (BV) due to Gardnerella vaginalis, Mycoplasma
hominis and various anaerobic bacteria including
Mobiluncus
sp., and Prevotella sp.
B. Epidemiology
Bacterial vaginosis (BV) is the most common cause of vaginitis symptoms
among women of childbearing age. BV--previously called nonspecific vaginitis
or Gardnerella-associated vaginitis-- can be transmitted through
sexual activity, although the organisms responsible also have been found
in young women who are not sexually active.
Bacterial vaginosis is caused by an overgrowth of bacteria rather than yeast or other organisms. These are primarily anaerobic bacteria (requiring no oxygen) and an organism called Gardnerella, all of which can be found in low numbers in the healthy vagina. In women with BV, the vaginal balance is disrupted so that these bacteria overgrow at the expense of protective bacteria known as lactobacilli. Lactobacilli excrete hydrogen peroxide to help maintain a healthy and normal balance of microorganisms in the vagina. Women who have been diagnosed with BV have been found to have up to 1,000 times more anaerobic bacteria than women without the disease. Instead of the normal predominance of Lactobacillus bacteria, increased numbers of organisms such as Gardnerella vaginalis, Bacteroides, Mobiluncus, and Mycoplasma hominis are found in the vagina in women with BV.
A few studies have also correlated BV with increased douching, an increased number of sexual partners and use of intrauterine devices. While sexual activity may increase the likelihood of developing BV, the condition has also been found in sexually inexperienced and monogamous women.
C. Manifestations
antibiotic therapy:
Metronidazole 500 mg orally twice a day for 7 days,
OR
Metronidazole gel 0.75%, one full applicator (5 g) intravaginally, once a
day for 5 days,
OR
Clindamycin cream 2%, one full applicator (5 g) intravaginally at bedtime
for 7 days..
BARBARA A. MAJERONI, M.D., 1998. Bacterial
Vaginosis: An Update. American Family Physician. March 15, 1998.
http://www.aafp.org/afp/980315ap/majeroni.html
Mycotic vulvovaginitis or vulvovaginal candidiasis
1. Epidemiology
When the delicate balance of organisms in the vagina is upset, the yeast may overgrow and cause vaginitis. For example, when a woman takes certain antibiotics to treat a bacterial infection, the antibiotic may also kill the lactobacilli that produce hydrogen peroxide to protect against yeast overgrowth. Other factors that may upset the balance and lead to yeast infection include pregnancy, obesity, diabetes, birth control pills, steroids, prolonged exposure to moisture and poor feminine hygiene.
Intravaginal Agents:
Butoconazole 2% cream 5 g intravaginally for 3 days,
OR
Butoconazole 2% cream 5 g (Butaconazole1-sustained release), single intravaginal application,
OR
Clotrimazole 1% cream 5 g intravaginally for 7--14 days,
OR
Clotrimazole 100 mg vaginal tablet for 7 days,
OR
Clotrimazole 100 mg vaginal tablet, two tablets for 3 days,
OR
Clotrimazole 500 mg vaginal tablet, one tablet in a single application,
OR
Miconazole 2% cream 5 g intravaginally for 7 days,
OR
Miconazole 100 mg vaginal suppository, one suppository for 7 days,
OR
Miconazole 200 mg vaginal suppository, one suppository for 3 days,
OR
Nystatin 100,000-unit vaginal tablet, one tablet for 14 days,
OR
Tioconazole 6.5% ointment 5 g intravaginally in a single application,
OR
Terconazole 0.4% cream 5 g intravaginally for 7 days,
OR
Terconazole 0.8% cream 5 g intravaginally for 3 days,
OR
Terconazole 80 mg vaginal suppository, one suppository for 3 days.Oral Agent:
Fluconazole 150 mg oral tablet, one tablet in single dose.
A. Etiology
The etiological agent is a flagellated protozoan Trichomonas vaginalis.
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
"whiff" test |
|
|
|
|
| Microscopic |
epithelial cells |
|
|
|
Send comments and mail to Dr. Neal R. Chamberlain, nchamberlain@atsu.edu
Revised 9/1/04
©2004 Neal R. Chamberlain, Ph.D., All rights reserved.